ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

PRM Proteome Sciences Plc

3.51
-0.04 (-1.13%)
14 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Proteome Sciences Plc LSE:PRM London Ordinary Share GB0003104196 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.04 -1.13% 3.51 3.02 4.00 - 303,907 16:35:20
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Biological Pds,ex Diagnstics 7.78M 1.33M 0.0045 7.89 10.48M
Proteome Sciences Plc is listed in the Biological Pds,ex Diagnstics sector of the London Stock Exchange with ticker PRM. The last closing price for Proteome Sciences was 3.55p. Over the last year, Proteome Sciences shares have traded in a share price range of 2.97p to 8.50p.

Proteome Sciences currently has 295,182,056 shares in issue. The market capitalisation of Proteome Sciences is £10.48 million. Proteome Sciences has a price to earnings ratio (PE ratio) of 7.89.

Proteome Sciences Share Discussion Threads

Showing 157526 to 157549 of 157550 messages
Chat Pages: 6302  6301  6300  6299  6298  6297  6296  6295  6294  6293  6292  6291  Older
DateSubjectAuthorDiscuss
14/5/2024
19:57
but do remember to adhere to those thread rules in the header Dom
elpirata
14/5/2024
19:51
Many thanks to the thread manager for reprieving this avatar from a death sentence!
dominiccummings
14/5/2024
17:04
Not now, actually Dom.
goatherd
14/5/2024
11:39
He shouldn’t expect anything - and then he won’t be (yet further) disappointed.
monte1
14/5/2024
11:01
Caneletto,

Yes, huge news. But on Therapeutics.

As you know Proteome is only working on diagnostics, so you should not expect a connection!

goatherd
14/5/2024
07:30
Huge medical news on Breakfast TV this morning involving stroke and ADI must have missed the mention of Prm front and centre.
canaletto
13/5/2024
15:48
Ah remember the days of CK1 Delta - alzheimers cure - if you are a mouse you have nothing to worry about any more.

Remember the doctor who had never seen anything like proteome in terms of predicting cancer pathways etc.

Sadly no more pie in the sky stuff.


Would be nice to see their US research lab winning a load of business and taking them into long term profitability, if they could get up to USD 20m a year they may even pay off the CJP loan.

octopus100
12/5/2024
19:25
#92913 You miss the bit where the Chairman tells attendees what pub he's visiting after the AGM, so drummimg up the attendees to buy his Gin & Tonic!
dominiccummings
12/5/2024
16:02
We will see,maybe just maybe they will pull something out of the hat.
peverill
12/5/2024
15:42
I am not so sure peverill. I live in hope!
goatherd
12/5/2024
15:19
The usual spiel,regurgitate some previous presentation with a new spin on it,you know the score Richard,you've done plenty of it and yet here we are,no further forward.
peverill
12/5/2024
15:04
And what is she going to say in the webcast presentation?
goatherd
12/5/2024
14:50
base7,

Yes, I share some of your thoughts on that. BUT we have been there before.

It could just be that the CEO got out of bed one morning and thought "Oh, its a long time since I made a presentation. Perhaps I should do one to show the shareholders I am earning my keep."

I do prefer your version, but I fear they are both possible versions; and, of course, there are many more.

goatherd
12/5/2024
12:53
AGM coming up,should last all of 20 minutes and see you all next year.And thanks for the steady wage and your patience.
peverill
11/5/2024
16:57
Proteome Sciences AGM is next Thursday at midday. This is broadcast live on the 'investormeetcompany' website.
pools2
11/5/2024
16:16
Interesting to note that there will be an Investor Meets next Thursday @ midday.These presentations usually take place within a day or two of results or following significant contract news.It will be 3 weeks after the recent RNS regarding the 500k contract, which I would not have thought would warrant a CEO presentation -so what might our CEO have to tell us next Thursday which we dont already know following results last month & the recent contract award ? The optimist in me hopes for an RNS ahead of Thursdays presentation which will explain clearly why our CEO considers it necessary to make a presentation.
base7
10/5/2024
12:59
One for those with long memories here - was it 2002 everyone starting getting excited about their biomarkers for this?
bluemango
08/5/2024
11:37
wasjobber?
monte1
08/5/2024
11:19
SINGLE CELL PROTEOMICS (SCP)

Over 1000 cells per day with TMTpro 32-plex

pools2
04/5/2024
05:56
As you were!!
peverill
01/5/2024
08:15
Presumably the other secondary avatar wasjobber is being prepped to verify that to be the case as we 'speak'?
barry evans
01/5/2024
07:30
I'm not sure investors fully appreciate the significance of Proteome Sciences new 32-plex TMTpro reagents, which will probably be officially announced by Thermo at this years ASMS in Anaheim early next month. It's not just a near doubling of the current 18-plex TMTpro reagent, but also a massive improvement of Thermo's mass spec capabilities, which will leave their competitors far behind them in performance and sample throughput.

One users perspective :-

www.proteomicsnews.blogspot.com/2024/04/is-tof-killing-technology-on-horizon.html

The new 32-plex TMTpro reagents will have big consequences for the mass spec proteomics market and its competitors.

pools2
28/4/2024
17:18
Thermo Fisher Scientific Reports First Quarter 2024 Results24th April 24Source: Business WireThermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the first quarter ended March 30, 2024.First Quarter 2024 HighlightsFirst quarter revenue was $10.34 billion.First quarter GAAP diluted earnings per share (EPS) increased 4% to $3.46.First quarter adjusted EPS increased 2% to $5.11.
goggin
26/4/2024
21:41
10p-ish...Ha! i suspect that gave The Diggles, the giggles. ~40Mln buyout after 30 years-ish.......The mind boggles.
cdlaney
Chat Pages: 6302  6301  6300  6299  6298  6297  6296  6295  6294  6293  6292  6291  Older

Your Recent History

Delayed Upgrade Clock